LU90097I2 - Ropinirole facultativement sous forme de sels pharmaceutiquement acceptables et de préférence le sel hydrochlorique - Google Patents
Ropinirole facultativement sous forme de sels pharmaceutiquement acceptables et de préférence le sel hydrochloriqueInfo
- Publication number
- LU90097I2 LU90097I2 LU90097C LU90097C LU90097I2 LU 90097 I2 LU90097 I2 LU 90097I2 LU 90097 C LU90097 C LU 90097C LU 90097 C LU90097 C LU 90097C LU 90097 I2 LU90097 I2 LU 90097I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- ropinirole
- optionally
- pharmaceutically acceptable
- acceptable salts
- hydrochloric salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/447,564 US4452808A (en) | 1982-12-07 | 1982-12-07 | 4-Aminoalkyl-2(3H)-indolones |
Publications (1)
Publication Number | Publication Date |
---|---|
LU90097I2 true LU90097I2 (fr) | 1997-07-16 |
Family
ID=23776840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU90097C LU90097I2 (fr) | 1982-12-07 | 1983-11-30 | Ropinirole facultativement sous forme de sels pharmaceutiquement acceptables et de préférence le sel hydrochlorique |
Country Status (27)
Country | Link |
---|---|
US (1) | US4452808A (fr) |
EP (1) | EP0113964B1 (fr) |
JP (1) | JPS59112964A (fr) |
KR (1) | KR910001042B1 (fr) |
AU (1) | AU560170B2 (fr) |
BR (1) | BR1100036A (fr) |
CA (1) | CA1208650A (fr) |
CY (1) | CY1497A (fr) |
CZ (1) | CZ398191A3 (fr) |
DE (1) | DE3367090D1 (fr) |
DK (1) | DK156514C (fr) |
DZ (1) | DZ587A1 (fr) |
EG (1) | EG16556A (fr) |
ES (2) | ES8600239A1 (fr) |
FI (1) | FI77849C (fr) |
GR (1) | GR79121B (fr) |
HK (1) | HK82089A (fr) |
IE (1) | IE56347B1 (fr) |
IL (1) | IL70311A (fr) |
LU (1) | LU90097I2 (fr) |
NL (1) | NL970005I2 (fr) |
NO (2) | NO160135C (fr) |
NZ (1) | NZ206344A (fr) |
PH (1) | PH22067A (fr) |
PT (1) | PT77739B (fr) |
ZA (1) | ZA839094B (fr) |
ZW (1) | ZW25883A1 (fr) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588740A (en) * | 1982-12-07 | 1986-05-13 | Smithkline Beckman Corporation | Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones |
US4657929A (en) * | 1983-10-25 | 1987-04-14 | Fisons Plc | Compounds |
US4554284A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones |
GB8621040D0 (en) * | 1986-08-30 | 1986-10-08 | Smith Kline French Lab | Process |
GB8712073D0 (en) * | 1987-05-21 | 1987-06-24 | Smith Kline French Lab | Medicament |
GB8714371D0 (en) * | 1987-06-19 | 1987-07-22 | Smith Kline French Lab | Process |
GB9008605D0 (en) * | 1990-04-17 | 1990-06-13 | Smith Kline French Lab | Process |
GB9015095D0 (en) * | 1990-07-09 | 1990-08-29 | Smith Kline French Lab | Therapeutic method |
IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
JPH07506823A (ja) * | 1992-05-18 | 1995-07-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 記憶障害,性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用 |
GB9300309D0 (en) * | 1993-01-08 | 1993-03-03 | Smithkline Beecham Plc | Process |
TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
US5807570A (en) * | 1995-09-29 | 1998-09-15 | Cygnus, Inc. | Transdermal administration of ropinirole and analogs thereof |
GB9526511D0 (en) * | 1995-12-23 | 1996-02-28 | Astra Pharma Prod | Pharmaceutically active compounds |
ES2179362T3 (es) * | 1996-08-27 | 2003-01-16 | Wyeth Corp | Derivados de 4-aminoetoxi indolona. |
ZA992670B (en) * | 1998-04-13 | 2000-10-12 | American Home Prod | 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists. |
US6218421B1 (en) * | 1999-07-01 | 2001-04-17 | Smithkline Beecham P.L.C. | Method of promoting smoking cessation |
AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
US6277875B1 (en) * | 2000-07-17 | 2001-08-21 | Andrew J. Holman | Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
WO2002069974A1 (fr) * | 2001-03-05 | 2002-09-12 | Andrew Holman | Administration d'agents restaurateurs de sommeil |
FR2821843B1 (fr) * | 2001-03-12 | 2003-05-09 | Servier Lab | Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US20030068356A1 (en) * | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
DK1545546T3 (da) * | 2002-09-13 | 2007-08-06 | Motac Neuroscience Ltd | Behandling af dyskinesi med 2,3-benzodiazepiner |
PT1539135E (pt) * | 2002-09-17 | 2007-07-12 | Motac Neuroscience Ltd | Tratamento da discinesia. |
ES2237307B1 (es) * | 2003-10-14 | 2006-11-01 | Urquima, S.A. | Procedimiento para la preparacion de ropinirol. |
WO2005074387A2 (fr) * | 2003-12-30 | 2005-08-18 | Sun Pharmaceutical Industries Limited | Nouvelles formes cristallines d'hydrochlorure de 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone |
US7378439B2 (en) * | 2004-01-20 | 2008-05-27 | Usv, Ltd. | Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
WO2005105741A1 (fr) * | 2004-02-11 | 2005-11-10 | Sun Pharmaceutical Industries Limited | Hydrochlorure de 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone sensiblement pur |
WO2005080333A1 (fr) * | 2004-02-19 | 2005-09-01 | Torrent Pharmaceuticals Ltd | Processus de purification de ropinirole |
CZ2006778A3 (cs) * | 2004-05-11 | 2007-03-07 | Egis Gyogyszergyár Nyrt. | Piperazinové deriváty alkyloxindolu |
HUP0400953A3 (en) * | 2004-05-11 | 2008-02-28 | Egis Gyogyszergyar Nyilvanosan | Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use |
US20050267096A1 (en) * | 2004-05-26 | 2005-12-01 | Pfizer Inc | New indazole and indolone derivatives and their use pharmaceuticals |
US20050288270A1 (en) * | 2004-05-27 | 2005-12-29 | Pfizer Inc | New aminopyridine derivatives and their use as pharmaceuticals |
US20080214622A1 (en) * | 2005-03-21 | 2008-09-04 | Alan Daniel Brown | Substituted Triazole Derivatives As Oxytocin Antagonists |
CN100457711C (zh) * | 2005-06-27 | 2009-02-04 | 上海奥博生物医药技术有限公司 | 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法 |
WO2007010557A2 (fr) * | 2005-07-22 | 2007-01-25 | Ind-Swift Laboratorie Limted | Methode de preparation de ropinirole tres pur |
ATE517865T1 (de) | 2006-03-29 | 2011-08-15 | Alembic Ltd | Verfahren zur aufreinigung von ropinirolhydrochlorid |
US8475829B2 (en) | 2006-04-06 | 2013-07-02 | Nupathe Inc. | Implants for the treatment of dopamine associated states |
US20070254941A1 (en) * | 2006-04-21 | 2007-11-01 | Glenmark Pharmaceuticals Limited | Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation |
CN100457732C (zh) * | 2006-05-25 | 2009-02-04 | 药源药物化学(上海)有限公司 | 罗匹尼罗的制备方法 |
WO2008001204A2 (fr) * | 2006-06-29 | 2008-01-03 | Antares Pharma Ipl Ag | Compositions transdermiques de pramipexole présentant des propriétés de perméation améliorées |
TW200815045A (en) * | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
RU2470635C2 (ru) * | 2007-05-11 | 2012-12-27 | Сантен Фармасьютикал Ко., Лтд. | Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза |
US20090076124A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched ropinirole |
US20090247537A1 (en) * | 2008-03-25 | 2009-10-01 | William Dale Overfield | Methods for preventing or treating bruxism using dopaminergic agents |
CN101574341B (zh) * | 2008-05-05 | 2012-12-19 | 北京德众万全医药科技有限公司 | 一种罗匹尼罗的口服固体药物组合物 |
US20110195117A1 (en) * | 2008-09-01 | 2011-08-11 | Lupin Limited | Controlled release compositions of ropinirole |
EP2452677A1 (fr) | 2008-09-29 | 2012-05-16 | Wockhardt Limited | Forme posologique à libération prolongée de ropinirole |
US20100130582A1 (en) * | 2008-11-24 | 2010-05-27 | Auspex Pharmaceuticals, Inc. | Indolinone modulators of dopamine receptor |
EP2438917B1 (fr) | 2009-05-21 | 2014-09-03 | Hisamitsu Pharmaceutical Co., Inc. | Préparation transdermique |
US20120253051A1 (en) * | 2009-12-16 | 2012-10-04 | Pharmathen S.A. | Process for the preparation of ropinirole and salts thereof |
JP5820469B2 (ja) | 2010-04-30 | 2015-11-24 | テイコク ファーマ ユーエスエー インコーポレーテッド | プロピニルアミノインダンの経皮組成物 |
CN101891641B (zh) * | 2010-07-27 | 2015-06-10 | 北京华禧联合科技发展有限公司 | 盐酸罗匹尼罗关键中间体的稳定形态及其制备 |
TWI537274B (zh) | 2011-03-14 | 2016-06-11 | 橘生藥品工業股份有限公司 | 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途 |
CN103476404B (zh) | 2011-03-24 | 2017-09-29 | 帝国制药美国公司 | 包含活性剂层和活性剂转化层的透皮组合物 |
US9913812B2 (en) | 2011-11-09 | 2018-03-13 | Teikoku Pharma Usa, Inc. | Methods for the treatment of skin neoplasms |
CA2887705C (fr) | 2012-11-02 | 2018-07-24 | Teikoku Pharma Usa, Inc. | Compositions transdermiques de propynylaminoindane |
US9585885B2 (en) | 2012-12-10 | 2017-03-07 | Kissei Pharmaceutical Co., Ltd. | Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists |
US9155695B2 (en) | 2013-03-14 | 2015-10-13 | Medtronic, Inc. | Injectable ropinirole compositions and methods for making and using same |
US10961194B2 (en) | 2017-06-16 | 2021-03-30 | Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. | Method for purifying ropinirole hydrochloride |
CN115466209A (zh) * | 2022-09-29 | 2022-12-13 | 南通大学 | 一种罗匹尼罗环戊烷并吲哚酮杂质的合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA895875A (en) * | 1972-03-21 | Bourdais Jacques | Mercapto indole derivatives | |
US3573310A (en) * | 1967-09-28 | 1971-03-30 | Miles Lab | 1-substituted derivatives of 2-indolinone |
JPS5840539B2 (ja) * | 1976-03-31 | 1983-09-06 | 大塚製薬株式会社 | α−置換アミノアルカノイルオキシインド−ル誘導体 |
JPS5825673B2 (ja) * | 1976-03-31 | 1983-05-28 | 大塚製薬株式会社 | オキシインド−ル誘導体 |
JPS5919537B2 (ja) * | 1976-08-02 | 1984-05-07 | 大塚製薬株式会社 | オキシインド−ル誘導体 |
US4317944A (en) * | 1980-08-15 | 1982-03-02 | General Electric Company | Preparation of 2,2-bis(4-hydroxyphenyl) propane |
US4314944A (en) * | 1980-08-22 | 1982-02-09 | Smithkline Corporation | 4-Aminoalkyl-7-hydroxy-2(3H)-indolones |
-
1982
- 1982-12-07 US US06/447,564 patent/US4452808A/en not_active Expired - Lifetime
-
1983
- 1983-11-17 CA CA000441416A patent/CA1208650A/fr not_active Expired
- 1983-11-21 NZ NZ206344A patent/NZ206344A/en unknown
- 1983-11-22 AU AU21585/83A patent/AU560170B2/en not_active Expired
- 1983-11-23 IL IL70311A patent/IL70311A/xx not_active IP Right Cessation
- 1983-11-25 ZW ZW258/83A patent/ZW25883A1/xx unknown
- 1983-11-25 PT PT77739A patent/PT77739B/pt unknown
- 1983-11-28 PH PH29901A patent/PH22067A/en unknown
- 1983-11-30 LU LU90097C patent/LU90097I2/fr unknown
- 1983-11-30 EP EP83307289A patent/EP0113964B1/fr not_active Expired
- 1983-11-30 DE DE8383307289T patent/DE3367090D1/de not_active Expired
- 1983-11-30 CY CY1497A patent/CY1497A/xx unknown
- 1983-12-02 FI FI834421A patent/FI77849C/fi not_active IP Right Cessation
- 1983-12-05 EG EG753/83A patent/EG16556A/xx active
- 1983-12-05 GR GR73156A patent/GR79121B/el unknown
- 1983-12-06 DK DK562183A patent/DK156514C/da not_active IP Right Cessation
- 1983-12-06 ES ES527827A patent/ES8600239A1/es not_active Expired
- 1983-12-06 IE IE2866/83A patent/IE56347B1/en not_active IP Right Cessation
- 1983-12-06 NO NO834485A patent/NO160135C/no unknown
- 1983-12-06 JP JP58231215A patent/JPS59112964A/ja active Granted
- 1983-12-07 KR KR1019830005790A patent/KR910001042B1/ko not_active IP Right Cessation
- 1983-12-07 ZA ZA839094A patent/ZA839094B/xx unknown
-
1984
- 1984-12-07 DZ DZ847014A patent/DZ587A1/fr active
-
1985
- 1985-05-29 ES ES543593A patent/ES8604143A1/es not_active Expired
-
1989
- 1989-10-12 HK HK820/89A patent/HK82089A/xx not_active IP Right Cessation
-
1991
- 1991-12-20 CZ CS913981A patent/CZ398191A3/cs unknown
-
1996
- 1996-08-30 BR BR1100036-8A patent/BR1100036A/pt active IP Right Grant
-
1997
- 1997-02-05 NL NL970005C patent/NL970005I2/nl unknown
-
1999
- 1999-06-18 NO NO1999011C patent/NO1999011I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU90097I2 (fr) | Ropinirole facultativement sous forme de sels pharmaceutiquement acceptables et de préférence le sel hydrochlorique | |
LU90593I2 (fr) | Quetiapine facutativement sous forme d'un sel pharmaceutiquement acceptabe | |
LU88809I2 (fr) | Lamivudine facultativement sous la forme d'un sel pharmaceutiquement acceptable | |
LU90426I2 (fr) | Abacavir facultativement sous la forme d'un sel pharmaceutiquement acceptable ou d'un d-rive y compris le sulfate d'abacavir | |
LU91290I2 (fr) | Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr) | |
LU88746I2 (fr) | Valaciclovir facultativement sous la forme d'un sel pharmaceutiquement acceptable y compris le sel d'addition de l'acide chlorhydrique | |
LU91147I2 (fr) | Pemetrexed et ses sels pharmaceutiquement acceptables. | |
BE875890A (fr) | Enlevement d'impuretes sous forme de parties par milliard de saumures alcalines | |
LU90468I2 (fr) | Zanamivir facultativement sous la forme d'un sel ou d'un derive pharmaceutiquement acceptable | |
LU88842I2 (fr) | Nebivolol optionnellement sous forme d'un sel ou d'un hydrate pharmaceutiquement acceptable en particulier hydroclorure de Nebivolol | |
LU88797I2 (fr) | Raltitrexed et ses sels esters et hydrates pharmaceutiquement acceptables | |
LU91306I2 (fr) | Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN) | |
LU92564I2 (fr) | Médocaril de ceftobiprole et les sels pharmaceutiquement acceptables qui en dérivent | |
FI913524A0 (fi) | Med vattenhaltigt zein belagda soetningsmedel och andra ingredienser foer tuggummi. | |
IT8620298A0 (it) | Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi. | |
FR2602421B1 (fr) | Composition sous forme de gel pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de piperidino-pyrimidine | |
ES537312A0 (es) | Procedimiento para la desintegracion de derivados de s-triacin en soluciones acuosas | |
FR2609391B1 (fr) | Preparations pharmaceutiques sous forme de suppositoires bioadhesifs | |
ITRM910026A0 (it) | Generatore di acqua dolce | |
DK670087D0 (da) | Apparat til brug ved afskaering af fisks hoveder | |
IT1170238B (it) | Impiego di ibuprofene e flurbiprofene nella cura dell'erpete | |
DK497088A (da) | Vandoploeselige polysakkarider samt fremstilling og anvendelse deraf | |
FR2542197B1 (fr) | Remede medicamenteux et prophylactique anticarie dentaire sous forme de granules | |
LU90070I2 (fr) | Zafirlukast optionnellement sous forme d'un sel de celui-ci | |
ITMI941939A0 (it) | Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids |